Laura Conti

Organogenesis (United States) — United States

Immunology and Microbiology · Life Sciences

37h-index3.4kcitations225works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(77), Cancer Research and Treatments(58), Cancer Cells and Metastasis(36), Nanoplatforms for cancer theranostics(35), Monoclonal and Polyclonal Antibodies Research(34)

Publications225 total

Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer
Cancers·2025Open Access
Special Issue: “Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets”
International Journal of Molecular Sciences·2025Open Access
In situ sonoporation to enhance the tumour uptake of silicon phthalocyanine and improve PDT effectiveness in a triple negative breast cancer murine model
Journal of Photochemistry and Photobiology B Biology·2025· 1 citedOpen Access
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Journal of Visualized Experiments·2025
Abstract 5846: A potent STING agonist induces endothelial PD-L1 and enhances antitumor efficacy of a novel PD-L1/PD-L2 antibody
Cancer Research·2025
Novel FAP-Targeted Heptamethine Cyanines for NIRF Imaging Applications
Molecular Pharmaceutics·2025· 5 citedOpen Access
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Molecular Aspects of Medicine·2024· 30 citedOpen Access
1023 Preclinical development of STING agonist 8803 (IMGS-203) for the treatment of solid tumors
Regular and Young Investigator Award Abstracts·2024Open Access
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Effect of Mitoquinone on sperm quality of cryopreserved stallion semen
Journal of Equine Veterinary Science·2024· 9 cited
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer
Journal of Experimental & Clinical Cancer Research·2024· 16 citedOpen Access
Small-angle X-ray and neutron scattering applied to lipid-based nanoparticles: Recent advancements across different length scales
Advances in Colloid and Interface Science·2024· 48 citedOpen Access
Supplementary Table 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Data from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 3 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Data from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Figure 6 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
Supplementary Table 1 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine
2024Open Access
page 1 of 12Next →

Frequent Co-authors

Federica Cavallo(31), Stefania Lanzardo(13), Roberto Ruiu(13), Elisabetta Bolli(12), Federica Riccardo(10), Elena Quaglino(9), Giuseppina Barutello(9), Francesco Novelli(7), Valeria Rolih(6), Silvio Aime(5), Mirella Giovarelli(5), Daniela Boselli(4), Maddalena Arigoni(4), Emilia Turco(4), Lidia Tarone(4), Irene Fiore Merighi(4), Gabriella Regis(4), Marco Macagno(3), Raffaele Calogero(3), Mara Brancaccio(3)